Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke

PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 15, 2025

Primary Completion Date

January 1, 2030

Study Completion Date

August 1, 2030

Conditions
Acute Ischemic Stroke
Interventions
DEVICE

High-definition Cathodal Transcranial Direct Current Stimulation (HD C-tDCS)

The active study treatment involves delivering a weak form of electrical stimulation via 5 small electrodes to the brain tissue at risk of infarction.

DEVICE

Sham tDCS

Sham patients will have cap and electrodes in place, but no stimulation will be delivered.

Trial Locations (3)

21287

RECRUITING

Johns Hopkins Medical Center, Baltimore

27710

RECRUITING

Duke Medical Center Hospital, Durham

90095

RECRUITING

University of California- Los Angeles (UCLA), Los Angeles

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Johns Hopkins University

OTHER

collaborator

Duke University

OTHER

collaborator

Cedars-Sinai Medical Center

OTHER

collaborator

University of California, San Francisco

OTHER

lead

University of California, Los Angeles

OTHER

NCT06440707 - Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter